DENALI ADVISORS LLC - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 118 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
DENALI ADVISORS LLC ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q2 2020$203,000
+23.8%
3,320
+14.5%
0.04%
+8.3%
Q1 2020$164,000
-1.8%
2,900
-1.4%
0.04%
+50.0%
Q4 2019$167,000
+8250.0%
2,941
+11211.5%
0.02%
Q2 2019$2,0000.0%260.0%0.00%
Q1 2019$2,000
-33.3%
26
-46.9%
0.00%
-100.0%
Q4 2018$3,000
-25.0%
49
-30.0%
0.00%0.0%
Q3 2018$4,000
+100.0%
70
+27.3%
0.00%
Q2 2018$2,0000.0%550.0%0.00%
Q1 2018$2,000
+100.0%
55
+150.0%
0.00%
Q4 2017$1,0000.0%22
-18.5%
0.00%
Q3 2015$1,000270.00%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q1 2019
NameSharesValueWeighting ↓
JW Asset Management, LLC 73,649$3,646,0002.32%
Stonepine Capital Management, LLC 59,878$2,965,0001.60%
NORTHPOINTE CAPITAL LLC 109,644$5,428,0000.57%
Elk Creek Partners, LLC 145,406$7,199,0000.47%
TFS CAPITAL LLC 18,208$901,0000.35%
RICE HALL JAMES & ASSOCIATES, LLC 161,671$8,004,0000.35%
Ativo Capital Management LLC 19,592$970,0000.26%
Matarin Capital Management, LLC 57,034$2,823,753,0000.26%
ISTHMUS PARTNERS, LLC 16,505$817,0000.24%
Stanley-Laman Group, Ltd. 12,546$621,0000.17%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders